Fisker cuts production guidance for Ocean EV after last-minute snags

Fisker cuts production guidance for Ocean EV after last-minute snags


Henrik Fisker stands with the Fisker Ocean electric vehicle after it was unveiled at the Manhattan Beach Pier ahead of the Los Angeles Auto Show and AutoMobilityLA on November 16, 2021 in Manhattan Beach, California.

Patrick T. Fallon | AFP | Getty Images

Electric vehicle startup Fisker on Tuesday reported a wider first-quarter loss than expected and cut its production guidance for the full year, both of which it blamed on last-minute snags as it begins production of its Ocean SUV.

But CEO Henrik Fisker told CNBC that the company expects regulatory approval to begin deliveries of the Ocean in the U.S. before the end of May. The company began delivering vehicles to customers in Europe last week.

related investing news

This semi stock could be in trouble as margin pressures grow, BMO says

CNBC Pro

Fisker’s shares were down about 12% in early trading after the news.

Here are the key numbers from Fisker’s first-quarter earnings report, together with consensus Wall Street estimates as reported by Refinitiv:

  • Loss per share: 38 cents, versus a loss of 30 cents expected.
  • Revenue: About $198,000, versus $14.4 million expected.

Fisker’s net loss for the quarter was $120.6 million, or 38 cents per share, a wider-than-expected number that the company attributed to higher research and development expenses that it’s not expecting to repeat. A year ago, Fisker reported a net loss of $122.1 million, or 41 cents a share, with no revenue.

Fisker had $652.5 million in cash remaining as of March 31, down from $736.5 million at the end of 2022. The company raised about $47 million via direct stock sales during the quarter, it said.

Fisker said it had about 65,000 reservations for the Ocean as of May 8, roughly the same number it had when it reported its fourth-quarter results in February. It has more than 6,000 reservations for its upcoming second model, a lower-cost EV called the Pear that will be built by Foxconn at the former Lordstown Motors plant in Ohio starting in 2025.

Fisker now expects its manufacturing partner, Magna International, to build 32,000 to 36,000 Oceans at its Austrian contract-manufacturing plant this year, down from 42,400 in its earlier guidance.

It said it expects to build 1,400 to 1,700 vehicles in the second quarter, assuming its suppliers ramp up as expected. After that, it expects to quickly increase production in the third quarter to a run rate of about 6,000 vehicles per month for the rest of 2023.

“We are ready to go full speed on production next week,” Henrik Fisker told CNBC’s Phil LeBeau on Tuesday. “[By the] end of this month, we are already going to produce 55 cars a day.”



Source

E.l.f. Beauty posts earnings beat, raises full-year guidance
Business

E.l.f. Beauty posts earnings beat, raises full-year guidance

Elf Beauty cosmetics Courtesy: e.l.f Beauty E.l.f. Beauty reported a huge earnings beat Wednesday and raised its guidance for the fiscal year. E.l.f. stock was up as much as 15% in after-hours trading before losing the majority of those gains. Here’s what the company reported for the third fiscal quarter, compared with analyst estimates from […]

Read More
Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs
Business

Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs

NFL Hall of Famer Terrell Owens said Wednesday that the recent snubs of New England Patriots owner Robert Kraft and former coach Bill Belichick from the institution show the system is flawed, and someone needs to be held accountable. “It’s just plain dumb” Owens told CNBC Sport in an interview in San Francisco ahead of […]

Read More
Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
Business

Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters It’s a tale of two drugmakers in the red-hot obesity drug market.  Both Novo Nordisk and Eli Lilly are grappling with lower prices in the U.S., but their 2026 outlooks are diverging sharply: While Novo is bracing for a sales decline, […]

Read More